[Federal Register Volume 69, Number 17 (Tuesday, January 27, 2004)]
[Notices]
[Page 3946]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-1649]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to section 1301.33(a) of title 21 of the Code of Federal 
Regulations (CFR), this is notice that on October 27, 2003, Cedarburg 
Pharmaceuticals, LLC, 870 Badger Circle, Grafton, Wisconsin 53024, made 
application by letter to the Drug Enforcement Administration (DEA) for 
registration as a bulk manufacturer of Fentanyl (9801), a basic class 
of Schedule II controlled substance.
    The firm plans to manufacture in bulk for distribution to 
customers.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substance may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: Federal Register Representative, 
Office of Chief Counsel (CCD) and must be filed no later than March 29, 
2004.

    Dated: December 19, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 04-1649 Filed 1-26-04; 8:45 am]
BILLING CODE 4410-09-M